by Tom Ballard – PYA Chief Alliance Officer

Knoxville’s EDP Biotech Corporation is one of 17 companies – and the only one from Tennessee – invited to pitch during the Southeast BIO (SEBIO) Investor & Partnering Forum scheduled next week in Coral Gables, FL.

“EDP Biotech is honored to be selected among all of the high-quality life science companies presenting at SEBIO 2019,” says Eric Mayer, the company’s Chief Executive Officer. “We are proud to represent the State of Tennessee and the cutting-edge technology being developed here, competing among companies from the biotech hubs like Research Triangle Park and larger metro areas like Atlanta and Miami. The selection validates all of the hard work and recent traction made by EDP Biotech’s team, opening new doors to active, early stage life science investors and potential strategic partners from the southeast region.”

For the company that is bringing to market its ColoPlex™ product to detect colorectal cancer at the earliest possible time, the conference is clearly a significant opportunity. More than 300 biotech and medtech investors, corporate executives, university representatives, and entrepreneurs are expected to be in attendance.

Read full blog article on TEKNOVATION.BIZ